Company intelligence
Phathom Pharmaceuticals
Going beyond to advance treatments for patients with acid-related disorders
About Phathom Pharmaceuticals
Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced start-up environment and contributing to our growth.
Verified activity
Signals from Phathom Pharmaceuticals
2 published signals
Operations & Supply
Phathom Pharmaceuticals will close its offices as it celebrates its PhathomPhamily and recognizes the hard work of workers across the country in observance of Labor Day.
Reported by Phathom Pharmaceuticals
Presence & Recognition
Phathom Pharmaceuticals leadership team members are gearing up to participate in the 2026 Cantor Fitzgerald Global Healthcare Conference on September 9 at 10:55am ET and the H.C. Wainwright & Co., LLC 28th Annual Global Investment Conference on September 15 at 3:30pm ET.
Reported by Phathom Pharmaceuticals